NEW YORK (GenomeWeb News) — LabVantage said yesterday that it has licensed its Sapphire Laboratory Information Management Suite to an undisclosed “global biopharmaceutical company” that is in the cancer and immunological disease market.
 
Bridgewater, NJ-based LabVantage said the biopharma will use the technology to automate their research process and establish an enterprise-wide knowledgebase of research data.  
 
Financial terms of the agreement were not released.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.